mci 9038 has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulani, Y; Sharma, SS | 1 |
| Aihara, K; Akaike, M; Fujinaka, Y; Ikeda, Y; Kinouchi, M; Kurahashi, K; Matsumoto, T; Mihara, M; Yoshida, S | 1 |
2 other study(ies) available for mci 9038 and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Fibrosis; Heart; Inflammation; Male; Myocardium; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Receptors, Proteinase-Activated; Signal Transduction; Sulfonamides | 2017 |
Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Adipose Tissue; Animals; Anticoagulants; Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Drug Tolerance; Factor VII; Humans; Insulin; Insulin Resistance; Interleukin-6; Macrophages; Mice; Mice, Inbred Strains; Pipecolic Acids; Platelet Aggregation Inhibitors; Receptors, CCR2; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sulfonamides; Thrombin | 2010 |